Management Archives - Page 58 of 341

2 minute read

Microsoft Grapples with Security Concerns Over Beijing AI Lab

January 11, 8:17 AM

Microsoft Corp (NASDAQ: MSFT) executives, including CEO Satya Nadella and President Brad Smith, have debated the future of their artificial intelligence lab in Beijing amid concerns about their close ties with China and the potential national security risks.

MSFT

1 minute read

YanGuFang International Announces Ya Zhang Interim CEO And Yang Sui As Interim CFO, Effective As Of January 9, 2024

By Benzinga Newsdesk

January 11, 3:03 AM

The Company has been informed by the family members of Mr. Junguo He, the Chief Executive Officer (the "CEO") and Chairman of the Board of Directors (the "Board") of the Company, and Mr. Kui Shi, the

YGF

2 minute read

Huntington Bancshares Announces Retirement Of Paul Heller, Chief Technology & Operations Officer, Effective March 1, 2024

By Benzinga Newsdesk

January 10, 5:40 PM

Amit Dhingra, Kendall Kowalski and Prashant Nateri named to bank's executive leadership teamCOLUMBUS, Ohio, Jan. 10, 2024 /PRNewswire/ -- Huntington Bancshares Incorporated (NASDAQ:HBAN) today announced the

HBAN

2 minute read

DocGo Rejects Short Seller Report And Releases Preliminary 2024 Revenue Guidance; Sees FY23 Revenue $615M-$625M Vs $619.24M Est.; FY24 Revenue To Exceed $700M Vs $760.2M Est.

By Benzinga Newsdesk

January 10, 5:02 PM

DocGo Inc. ("DocGo" or the "Company") categorically rejects this purported assessment by Fuzzy Panda Research, an obscure short seller motivated solely by profit. Their so-called "research report" uses what appears to be

DCGO

2 minute read

Tinder Names New CEO While it Struggles to Retain Users

By Anusuya Lahiri

January 10, 9:47 AM

Match Group Inc (NASDAQ: MTCH) has appointed Faye Iosotaluno as the new CEO of Tinder, its flagship

BMBL

2 minute read

Beacon Announces The Appointment Of Carmelo Carrubba, Beacon’s Current Vice President Of Strategy And Transformation, As Interim Chief Financial Officer, Effective January 20, 2024

By Benzinga Newsdesk

January 10, 9:19 AM

Appointment of Carmelo Carrubba as Interim Chief Financial OfficerBeacon today announced the appointment of Carmelo Carrubba, Beacon's current Vice President of Strategy and Transformation, as Interim Chief Financial

BECN

1 minute read

Semantix Announces Resignation Of Mr. Adriano Alcalde, Chief Financial Officer, To Be Effective On May 1, 2024; The Board Of Directors And Executive Leadership Team Are Actively Engaged In The Succession Planning Process

By Benzinga Newsdesk

January 10, 9:07 AM

Semantix, Inc. ("Semantix" or "the Company") (NASDAQ:STIX), a leading Latin American enterprise AI platform and applications provider, today announces the resignation of Mr. Adriano Alcalde, Chief Financial Officer, to

STIX

1 minute read

Fortune Rise Acquisition Corporation Names Director Ryan Spick as Principal Executive Officer And Chief Financial Officer

By Benzinga Newsdesk

January 9, 5:20 PM

Fortune Rise Acquisition Corporation (NASDAQ:FRLA) ("FRLA") today announced that Ryan Spick has recently moved from FRLA's Board to the role of Principal Executive Officer and Chief Financial Officer to execute on its

FRLA

6 minute read

Terreno Realty Corporation Announces Quarterly Operating, Investment And Capital Markets Activity, And Promotion Of John Meyer To Chief Operating Officer, Effective January 8, 2024; 98.5% Quarter-End Occupancy

By Benzinga Newsdesk

January 9, 5:16 PM

98.5% quarter-end occupancy compared to prior quarter of 98.3% and prior year of 98.6%98.5% quarter-end same-store occupancy compared to prior quarter of 98.7% and prior year of 98.8%47.5% increase in cash rents on new

TRNO

4 minute read

C4 Therapeutics Announces 2024 Priorities; Unaudited Cash, Cash Equivalents and Marketable Securities Totaling ~$330M As of January 5, 2024 To Advance Portfolio Of Targeted Protein Degradation Medicines; Announces Workforce Reduction Of ~30%

By Benzinga Newsdesk

January 9, 5:04 PM

Multiple 2024 Clinical Updates Expected, Including Data from the Ongoing CFT7455 and CFT1946 Phase 1 Dose Escalation Trials Prioritization of CFT7455, CFT1946, Discovery Collaborations and Focused Discovery Research

CCCC